As of November 2024 Regeneron Pharmaceuticals has 0 shares outstanding, a of - from 2023. It represents the total number of shares of a company that are owned by all its shareholders, including both public investors and company insiders.
Year | Shares outstanding | Change |
---|---|---|
2022 | 107.10M | 1.32% |
2021 | 105.70M | -1.77% |
2020 | 107.60M | - |